| Financial Year |
March 31 2023 |
| Monetary Funds |
821,255,693.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
27,144,131.64 |
| Advances to Suppliers |
3,482,900.68 |
| Other Receivables |
32,543,601.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,571,941,586.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
144,829,533.38 |
| Total Current Assets |
2,616,197,447.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
359,495,422.86 |
| Fixed Assetes |
186,472,159.73 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,505,347.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
169,663,023.29 |
| Deferred Income Tax Assets |
3,556,213.02 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
959,939,368.01 |
| Total Assets |
3,576,136,815.95 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
173,558,208.88 |
| Accounts Received In Advance |
1,773,241.29 |
| Employee Compensation Payable |
9,277,974.90 |
| Taxes Payable |
17,525,752.57 |
| Interest Payable |
-- |
| Dividend Payable |
28,723.83 |
| Other payables |
25,874,880.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,292,392.31 |
| Other Current Liabilities |
86,371,823.36 |
| Sub-Total of Current Liabilities |
1,282,209,919.07 |
| Long-term Loans |
339,015,633.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
52,651.42 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
413,880,858.90 |
| Total Liabilities |
1,696,090,777.97 |
| Paid-In Capital(Or Share Stock) |
499,215,811.00 |
| Capital Surplus |
478,268,073.88 |
| Surplus Reserve |
144,191,683.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
758,370,470.02 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,880,046,037.98 |
| Owner's Equity（Stockholder's Equity） |
1,880,046,037.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,576,136,815.95 |
